Skip to main content

Articles

Page 4 of 19

  1. Consistent and complete adherence is considered an essential requirement for patients on antiretroviral therapy (ART). This study aimed to evaluate the impact of ART duration on ART adherence, identify the tre...

    Authors: Kedi Jiao, Meizhen Liao, Guangmei Liu, Yanmei Bi, Xiuhong Zhao, Qian Chen, Jing Ma, Yu Yan, Chunxiao Cheng, Yijun Li, Wenwen Jia, Lina Wang, Yanwen Cao, Zhonghui Zhao, Xuan Yang, Jing Meng…
    Citation: AIDS Research and Therapy 2022 19:55
  2. Viral load (VL) monitoring of pregnant women living with HIV (PWLHIV) and antiretroviral therapy (ART) may contribute to lowering the risk of vertical transmission of HIV. The aims of this study were to assess...

    Authors: Christine Chiedza Chakanyuka Musanhu, Kudakwashe C. Takarinda, Jawaya Shea, Inam Chitsike and Brian Eley
    Citation: AIDS Research and Therapy 2022 19:52
  3. Monitoring of adherence to antiretroviral treatment (ART) is of utmost importance to prevent treatment failure. Several measures to monitor adherence have been applied in low-resource settings and they all hav...

    Authors: Kennedy M. Ngowi, Linda Minja, I. Marion Sumari-de Boer, Rob E. Aarnoutse, Lyidia Masika, Mirjam A. G. Sprangers, Francis M. Pima, Blandina T. Mmbaga, Peter Reiss and Pythia T. Nieuwkerk
    Citation: AIDS Research and Therapy 2022 19:51
  4. Medication adherence is important to the survival of People Living with HIV (PLHIV) globally. Although, HIV viral load is reduced by antiretroviral therapy (ART), the number of people on ART continues to rise ...

    Authors: Collins Adu, Kofi Akohene Mensah, Bright Opoku Ahinkorah, Dorothy Osei, Andrews William Tetteh and Abdul-Aziz Seidu
    Citation: AIDS Research and Therapy 2022 19:50
  5. We aimed to explore the association between PrEP-related stereotypes and perceived disapproval (hereafter PrEP-related stigma), and PrEP use.

    Authors: Oscar Javier Pico-Espinosa, Mark Hull, Paul MacPherson, Daniel Grace, Mark Gaspar, Nathan Lachowsky, Saira Mohammed, James Demers, Marshall Kilduff, Robinson Truong and Darrell H. S. Tan
    Citation: AIDS Research and Therapy 2022 19:49
  6. Authors: Juan Ignacio García, Johanna Meléndez, Rosa Álvarez, Carlos Mejía-Chew, Holden V. Kelley, Sabeen Sidiki, Alejandra Castillo, Claudia Mazariegos, Cesar López-Téllez, Diana Forno, Nancy Ayala, Joan-Miquel Balada-Llasat, Carlos Rodolfo Mejía-Villatoro, Shu-Hua Wang, Jordi B. Torrelles and Janet Ikeda
    Citation: AIDS Research and Therapy 2022 19:48

    The original article was published in AIDS Research and Therapy 2020 17:62

  7. People living with HIV (PLHIV) have higher risk of COVID-19 infection and mortality due to COVID-19. Health professionals should be able to assess PLHIV who are more likely to develop severe COVID-19 and provi...

    Authors: Evy Yunihastuti, Teguh Harjono Karjadi, Alvina Widhani, Haridana Indah Setiawati Mahdi, Salma Sundari, Aljira Fitya Hapsari, Sukamto Koesnoe and Samsuridjal Djauzi
    Citation: AIDS Research and Therapy 2022 19:47
  8. Previous clinical data have shown that raltegravir-based antiretroviral therapy (ART) with fewer drug-drug interactions (DDIs) and adverse events (AEs) is a good regimen in patients with HIV infection who need...

    Authors: Jing Yang, Guo Wei, Fuqiang Gui, Yong Zhao, Tingyu Chen and Juan Tan
    Citation: AIDS Research and Therapy 2022 19:45
  9. Due to improved coverage and scale-up of antiretroviral therapy (ART), patients are increasingly transferring between ART-providing sites. Self-transfers may constitute a high proportion of patients considered...

    Authors: Arnold Ssemwogerere, Javilla Kakooza Kamya, Lillian Nuwasasira, Claire Ahura, Derrick Isaac Isooba, Edith K. Wakida, Celestino Obua and Richard Migisha
    Citation: AIDS Research and Therapy 2022 19:44
  10. Although combined antiretroviral therapy (cART) has decreased the mortality associated with HIV infection, complete immune reconstitution is not achieved despite viral suppression. Alterations of CD8+ T cells and...

    Authors: Federico Perdomo-Celis, David Arcia-Anaya, Juan Carlos Alzate, Paula A. Velilla, Francisco J. Díaz, Maria Paulina Posada, María T. Rugeles and Natalia A. Taborda
    Citation: AIDS Research and Therapy 2022 19:42
  11. The South African public antiretroviral therapy (ART) programme is considered one of the largest and most successful ART programmes worldwide. Hence, a study exploring the patients’ experiences of the public a...

    Authors: Delarise M. Mulqueeny and Myra Taylor
    Citation: AIDS Research and Therapy 2022 19:41
  12. Patients with acquired immunodeficiency syndrome (AIDS) tend to suffer from several central nervous system (CNS) infections due to hypoimmunity. However, CNS aspergillosis (CNSAG) is extremely rare and difficu...

    Authors: Hong-Hong Yang, Xue-Jiao He, Jing-Min Nie, Shao-Shan Guan, Yao-Kai Chen and Min Liu
    Citation: AIDS Research and Therapy 2022 19:40
  13. The chronic illness trajectory and its outcomes are well explained by the concept of illness identity; the extent to which ill individuals have integrated their diagnosed chronic illness into their identity or...

    Authors: Neo Phyllis Sematlane, Lucia Knight, Caroline Masquillier and Edwin Wouters
    Citation: AIDS Research and Therapy 2022 19:39
  14. Data on safety and effectiveness of RPV from the real-world setting as well as comparisons with other NNRTIs such as efavirenz (EFV) remain scarce.

    Authors: Alessandro Cozzi-Lepri, Lars Peters, Annegret Pelchen-Matthews, Bastian Neesgaard, Stephane De Wit, Isik Somuncu Johansen, Simon Edwards, Christoph Stephan, Georgios Adamis, Therese Staub, Alexandra Zagalo, Pere Domingo, Daniel Elbirt, Katharina Kusejko, Johanna Brännström, Dzmitry Paduta…
    Citation: AIDS Research and Therapy 2022 19:38
  15. Polypharmacy in people living with HIV/AIDS (PLWHA) is a rising morbidity that exacts hefty economic burden on health budgets in addition to other adverse clinical outcomes. Despite recent advances, uncertaint...

    Authors: Mohammed Ibn-Mas’ud Danjuma, Safah Khan, Farah Wahbeh, Lina Mohammad Naseralallah, Unwam E. Jumbo and Abdelnaser Elzouki
    Citation: AIDS Research and Therapy 2022 19:37
  16. We describe a case of a 30-year-old MSM recently diagnosed with HIV, immunocompromised with a purplish or brown rash all over the body for 3 to 4 months. The histopathology of the cutaneous lesions and pleural...

    Authors: Sampada Bangar, Rohit Vashisht, Pratiksha Sonar, Kunal Ghule, Leena Rawat, Arati Mane, Abhijit Kadam, Nomita Chandhiok and Seema Sahay
    Citation: AIDS Research and Therapy 2022 19:36
  17. Strategies to support adherence are constrained by the lack of tools to objectively monitor medication intake in low-resource settings. Pharmacologic measures are objective, but pharmacy refill data is more ac...

    Authors: Jacinta N. Nwogu, Samuel O. Ngene, Chinedum P. Babalola, Adeniyi Olagunju, Andrew Owen, Saye H. Khoo, Olayinka A. Kotila, Baiba Berzins, Hideaki Okochi, Regina Tallerico, Monica Gandhi and Babafemi Taiwo
    Citation: AIDS Research and Therapy 2022 19:35
  18. Since the scale-up of routine viral load (VL) testing started in 2016, there is limited evidence on VL suppression rates under programmatic settings and groups at risk of non-suppression. We conducted a study ...

    Authors: Trudy Tholakele Mhlanga, Bart K. M. Jacobs, Tom Decroo, Emma Govere, Hilda Bara, Prosper Chonzi, Ngwarai Sithole, Tsitsi Apollo, Wim Van Damme, Simbarashe Rusakaniko, Lutgarde Lynen and Richard Makurumidze
    Citation: AIDS Research and Therapy 2022 19:34
  19. Multi-types COVID-19 vaccines have shown safety and efficacy against COVID-19 in adults. Although current guidelines encourage people living with HIV (PLWH) to take COVID-19 vaccines, whether their immune resp...

    Authors: Shi Zou, Mengmeng Wu, Fangzhao Ming, Songjie Wu, Wei Guo, Gifty Marley, Zhongyuan Xing, Zhiyue Zhang, Minxia Zeng, Chao Sun, Jianfeng Zhang, Weiming Tang and Ke Liang
    Citation: AIDS Research and Therapy 2022 19:33
  20. This study investigated prevalence trends and identified the associated factors of HIV, syphilis and hepatitis C virus (HCV) among pregnant women in the Guangxi Zhuang Autonomous Region (Guangxi), Southwest Ch...

    Authors: Shanmei Zhong, Yanyun Ou, Fei Zhang, Zhaosen Lin, Rongye Huang, Aidan Nong, Zhenxian Wu, Huayue Liang, Cai Qin, Qiuyu Wei, Yuan Yang, Dee Yu, Xianyan Tang, Li Ye, Deping Liu, Hao Liang…
    Citation: AIDS Research and Therapy 2022 19:31
  21. Understanding the experiences, needs, preferences, and behaviors of people living with HIV (PLHIV) are critical to tailor HIV treatment. However, there is limited empirical evidence in Ethiopia on the views of...

    Authors: Yihalem Abebe Belay, Mezgebu Yitayal, Asmamaw Atnafu and Fitalew Agimass Taye
    Citation: AIDS Research and Therapy 2022 19:30
  22. There is no other better way to safeguard an infant’s health in the first 6 months of life than exclusive breastfeeding (EBF). Breast milk is valuable in all aspects of an infant’s physical and mental growth a...

    Authors: Rose Faustine and Fabiola Vincent Moshi
    Citation: AIDS Research and Therapy 2022 19:29
  23. Pre-exposure prophylaxis (PrEP) represents a proven biomedical strategy to prevent HIV transmissions among men who have sex with men (MSM) in the United States (US). Despite the design and implementation of va...

    Authors: Ying Wang, Jason W. Mitchell, Chen Zhang and Yu Liu
    Citation: AIDS Research and Therapy 2022 19:28
  24. It has been widely noted that lifetime adherence to antiretroviral therapy (ART) is necessary for HIV treatment outcome; however, retention on ART among people living with HIV (PLWH) remains a great challenge ...

    Authors: Philomena J. Strother, Mathuros Tipayamongkholgul, Varakorn Kosaisevee and Nawarat Suwannapong
    Citation: AIDS Research and Therapy 2022 19:27
  25. We conducted a pilot trial of an intervention targeting intersectional stigma related to being pregnant and living with HIV while promoting capabilities for achieving ‘respected motherhood’ (‘what matters most...

    Authors: Lawrence H. Yang, Evan L. Eschliman, Haitisha Mehta, Supriya Misra, Ohemaa B. Poku, Patlo Entaile, Timothy D. Becker, Tadele Melese, Merrian J. Brooks, Marlene Eisenberg, Melissa A. Stockton, Karen Choe, Danielle Tal, Tingyu Li, Vivian F. Go, Bruce G. Link…
    Citation: AIDS Research and Therapy 2022 19:26
  26. Routine screening for HIV and other sexually transmitted infections (STIs) facilitates early diagnosis and treatment, thereby preventing morbidity and onward transmission. We estimated the prevalence of prior ...

    Authors: Trevor A. Crowell, Sorachai Nitayaphan, Narongrid Sirisopana, Tanyaporn Wansom, Suchai Kitsiripornchai, Leilani Francisco, Qun Li, Nicole Dear, Robert J. O’Connell, Punnee Pitisuttithum and Sandhya Vasan
    Citation: AIDS Research and Therapy 2022 19:25
  27. Evidence on health-related quality of life (HRQoL) outcomes is limited for new antiretroviral therapies (ART). Dolutegravir-based treatment is being rolled out as the preferred first-line treatment for HIV in ...

    Authors: Perez Nicholas Ochanda, Mohammed Lamorde, Kenneth Kintu, Duolao Wang, Tao Chen, Thokozile Malaba, Landon Myer, Catriona Waitt, Helen Reynolds and Saye Khoo
    Citation: AIDS Research and Therapy 2022 19:24
  28. People living with HIV (PLWHIV) commencing antiretroviral therapy (ART) in sub-Saharan Africa experience significant mortality within the first year. Previously, identified risk factors for mortality may be bi...

    Authors: Bradley W. Byers, Douglas Drak, Tinei Shamu, Cleophas Chimbetete, Rumbi Dahwa and David M. Gracey
    Citation: AIDS Research and Therapy 2022 19:23
  29. The initial cases of COVID-19 appeared in December 2019 and Spain was one of the most affected countries during the first wave (March to June). Since then, HIV HGM BioBank has been restructured as an establish...

    Authors: Consuegra Irene, Mauleón Elba, José Luis Jiménez, María José Mellado and María Ángeles Muñoz-Fernández
    Citation: AIDS Research and Therapy 2022 19:22
  30. Viral suppression remains the most desired outcome in the management of patients with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) and this can be achieved by an effective Antire...

    Authors: Stephen Opoku, Samuel Asamoah Sakyi, Nana Kwame Ayisi-Boateng, Anthony Kwame Enimil, Ebenezer Senu, Richard Owusu Ansah, Bismark Dankwah Aning, Diana Atsieno Ojuang, Doreen Nafula Wekesa, Fatima Osman Ahmed, Chidinma B. Okeke and Ama Darkoaa Sarfo
    Citation: AIDS Research and Therapy 2022 19:21
  31. Cryptococcal meningitis (CM) associated immune reconstitution inflammatory syndrome (CM-IRIS) is the second most common complication in HIV-infected individuals with cryptococcal meningitis, with a reported mo...

    Authors: Xiaoxu Han, Hui Liu, Yuqi Wang, Peng Wang, Xin Wang, Yunyun Yi and Xin Li
    Citation: AIDS Research and Therapy 2022 19:20
  32. Intestinal parasites and HIV/AIDS co-infection become a major public health concern in Africa. The management and care of HIV/AIDS patients is being complicated by intestinal parasitic infections. Therefore, t...

    Authors: Daniel Getacher Feleke, Abdurahaman Ali, Habtye Bisetegn and Mengaye Andualem
    Citation: AIDS Research and Therapy 2022 19:19
  33. In low income countries such as Uganda progress has been made towards achieving the United Nations AIDS programme 95-95-95 target however efforts are still impeded by pretreatment drug resistance and adverse d...

    Authors: Angella Namulindwa, John Hans Wasswa, Winnie Muyindike, Robert Tamukong and Joseph Oloro
    Citation: AIDS Research and Therapy 2022 19:18
  34. Medication adherence plays a pivotal role in achieving the desired treatment outcomes. The proportion of HIV patients on second-line antiretroviral therapy is becoming a growing public health concern. However,...

    Authors: Shambel Wedajo, Getu Degu, Amare Deribew and Fentie Ambaw
    Citation: AIDS Research and Therapy 2022 19:17
  35. Cytomegalovirus (CMV) has been linked with cardiovascular disease (CVD) in populations where some individuals are seronegative. However, effects of CMV are unclear in HIV patients who all have high levels of C...

    Authors: Ibnu A. Ariyanto, Riwanti Estiasari, Birry Karim, Ika Praseya Wijaya, Budiman Bela, Amin Soebandrio, Patricia Price and Silvia Lee
    Citation: AIDS Research and Therapy 2022 19:16
  36. Thanks to direct-acting antivirals, hepatitis C virus (HCV) infection can be cured, with similar rates in HCV-infected and HIV–HCV co-infected patients. HCV cure is likely to foster behavioral changes in psych...

    Authors: Tangui Barré, Patrick Mercié, Caroline Lions, Patrick Miailhes, David Zucman, Hugues Aumaître, Laure Esterle, Philippe Sogni, Patrizia Carrieri, Dominique Salmon-Céron and Fabienne Marcellin
    Citation: AIDS Research and Therapy 2022 19:15
  37. The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the pathophysiological mechanism of HIV-associ...

    Authors: Takanobu Mashiko, Kunihisa Tsukada, Hitomi Takada, Szu-Hsien Wu, Koji Kanayama, Rintaro Asahi, Masanori Mori, Akira Kurisaki, Shinichi Oka and Kotaro Yoshimura
    Citation: AIDS Research and Therapy 2022 19:14
  38. Patient preferences for long-acting antiretroviral therapies (LA-ART) should inform development of regimens with optimal adherence and acceptability. We describe a systematic process used to identify attribute...

    Authors: Aaron T. Brah, Douglas Barthold, Brett Hauber, Ann C. Collier, Rodney J. Y. Ho, Vincent C. Marconi, Jane M. Simoni and Susan M. Graham
    Citation: AIDS Research and Therapy 2022 19:13
  39. Pre-Exposure Prophylaxis (PrEP) has demonstrated efficacy in the reduction of sexually transmitted HIV infections. The prolonged use of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) co-formulatio...

    Authors: Karla Cristina Silva Petruccelli, Djane Clarys Baía-da-Silva, Fernando Val, Monica Santos Valões, Nadia Cubas-Vega, Alexandre Vilhena Silva-Neto, Vanderson Sampaio, Aline Alencar, Roberto Pecoits-Filho, Rodrigo Carvalho Moreira, Sandra Wagner Cardoso, Ronaldo I. Moreira, Iuri Costa Leite, José Valdez Madruga, Esper G. Kallas, Paulo R. Alencastro…
    Citation: AIDS Research and Therapy 2022 19:12
  40. In Nigeria, private for-profit health facilities present an opportunity to achieve the UNAIDS 95-95-95 HIV targets because of their reach and patronage. However, little is known about determinants of outcomes ...

    Authors: Muyi Aina, Zeena Yesufu, Abdulateef Salisu, Echezona Ezeanolue, Charles Mensah and Patrick Dakum
    Citation: AIDS Research and Therapy 2022 19:11
  41. Zambia recently achieved UNAIDS 90-90-90 treatment targets for HIV epidemic control; however, inpatient facilities continue to face a large burden of patients with advanced HIV disease and HIV-related mortalit...

    Authors: Nyuma Mbewe, Michael J. Vinikoor, Sombo Fwoloshi, Mundia Mwitumwa, Shabir Lakhi, Suilanji Sivile, Mallika Yavatkar, Brianna Lindsay, Kristen Stafford, Lottie Hachaambwa, Lloyd Mulenga and Cassidy W. Claassen
    Citation: AIDS Research and Therapy 2022 19:10
  42. Estimating the population sizes of key populations(people who inject drugs, men who have sex with men, transgender persons, and commercial sex workers) is critical for understanding the overall Human Immunodef...

    Authors: Chen Xu, Fengshi Jing, Ying Lu, Yuxin Ni, Joseph Tucker, Dan Wu, Yi Zhou, Jason Ong, Qingpeng Zhang and Weiming Tang
    Citation: AIDS Research and Therapy 2022 19:9
  43. Infant antiretroviral prophylaxis has an important role in reduction of Human immune virus transmission from mother to child during the postpartum period. Male partner involvement was considered as a priority ...

    Authors: Tamirat Melis and Yohannes Fikadu
    Citation: AIDS Research and Therapy 2022 19:8
  44. Support groups for people living with the Human Immunodeficiency Virus (HIV) have continued to evolve since their emergence over two decades ago. In addition to providing HIV education and fostering psychosoci...

    Authors: Fine Mazambara, Dexter Chagwena, Tinashe Mudzviti, Samantha Sithole, Tsitsi Monera-Penduka, Charles C. Maponga and Gene D. Morse
    Citation: AIDS Research and Therapy 2022 19:7
  45. In hospitalized people with HIV (PWH) there is an increased risk of mortality from COVID-19 among hospitalized PWH as compared to HIV-negative individuals. Evidence suggests that tocilizumab—a humanized monocl...

    Authors: Samuel J. Minkove, Grant Geiger, Josep M. Llibre, Mary W. Montgomery, Natalie E. West, Natasha M. Chida, Annukka A. R. Antar, Dima Dandachi and Ethel D. Weld
    Citation: AIDS Research and Therapy 2022 19:6
  46. Maintaining optimal adherence and viral suppression in people living with HIV (PLWH) is essential to ensure both preventative and therapeutic benefits of antiretroviral therapy (ART). Prisoners bear a particul...

    Authors: Terefe Gone Fuge, George Tsourtos and Emma R. Miller
    Citation: AIDS Research and Therapy 2022 19:5